piribedil has been researched along with Akinetic-Rigid Variant of Huntington Disease in 4 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meltzer, HY | 1 |
| Majeron, MA | 1 |
| Ambrosoli, C | 1 |
| Armocida, G | 1 |
| Finavera, L | 1 |
| Quisi, Q | 1 |
| Lieberman, AN | 1 |
| Shopsin, B | 1 |
| Brun, YL | 1 |
| Boal, D | 1 |
| Zolfaghari, M | 1 |
| Shoulson, I | 1 |
| Chase, T | 1 |
1 review available for piribedil and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Dopamine autoreceptor stimulation: clinical significance.
Topics: Apomorphine; Dopamine; Haloperidol; Humans; Huntington Disease; Mental Disorders; Neurons; Parkinson | 1982 |
2 trials available for piribedil and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Studies on piribedil in Parkinsonism.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Humans; Huntington Disease; Mental Disorders | 1975 |
Caffeine and the antiparkinsonian response to levodopa or piribedil.
Topics: Adult; Aged; Caffeine; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Female; | 1975 |
1 other study available for piribedil and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
[Attempted direct etiological treatment of Huntington's chorea. Case reports].
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Haloperidol; Humans; Huntington Disea | 1980 |